Fentermin
Prijeđi na navigaciju
Prijeđi na pretragu
| |||
| |||
| (IUPAC) ime | |||
|---|---|---|---|
| 2-metil-1-fenilpropan-2-amin | |||
| Klinički podaci | |||
| Robne marke | Adipex-P, Duromine, Fastin, Inoamin | ||
| AHFS/Drugs.com | Monografija | ||
| Identifikatori | |||
| CAS broj | 122-09-8 | ||
| ATC kod | A08AA01 | ||
| PubChem[1][2] | 4771 | ||
| DrugBank | DB00191 | ||
| ChemSpider[3] | 4607 | ||
| KEGG[4] | C07438 
| ||
| ChEMBL[5] | CHEMBL8080
| ||
| Hemijski podaci | |||
| Formula | C10H15N | ||
| Mol. masa | 149.2328 | ||
| SMILES | eMolekuli & PubHem | ||
| |||
| Fizički podaci | |||
| Tačka topljenja | 205 °C (401 °F) | ||
| Farmakokinetički podaci | |||
| Poluvreme eliminacije | 16 do 31 sati | ||
| Farmakoinformacioni podaci | |||
| Trudnoća | ? | ||
| Pravni status | |||
| Način primene | Oralno | ||
Fentermin je stimulans centralnog nervnog sistema i simpatomimetik sa dejstvom i primenom sličnom sa dekstroamfetaminu. On je korišten za tretiranje gojaznosti. Naka od tržišnih imena su: -[Adipex-P i Suprenza. Fentermin je takođe dostupan u kombinacijama sa drugim lekovima, kao što je Qsymia.[6][7][8][9]
Reference[uredi | uredi kod]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.
- ↑ Bray GA: A concise review on the therapeutics of obesity. Nutrition. 2000 Oct;16(10):953-60. PMID 11054601
- ↑ Nelson DL, Gehlert DR: Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine. 2006 Feb;29(1):49-60. PMID 16622292
- ↑ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. PMID 21059682.
- ↑ Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. PMID 18048412.
